Hepatocellular carcinoma- risk factors and survival duration after the treatment

A study on 523 patients with hepatocellular carcinoma in Central Army hospital during 1994-2002 has shown that average ages was 52,4+/- 13,2. The main etiology of hepatocellular carcinoma was hepatitis B virus. The survival duration in 5 groups of patients with hepatocellular carcinoma treated with PEIT, TOCE, surgery, chemotherapy and symptomatic treatment were 19,67; 11,3; 7; 9,2 and 2,7 months, respectively

Prognosis and monitoring significant of lectin affinity Alpha-fetoprotein in patients with hepatocellular carcinoma treated by transcatheter oil chemoembolization (TOCE)

20 patients selected from 60 patients with hepatocellular carcinoma who treated by transcatheter oil chemoembolization (TOCE). The patients diagnosed by cytology or history, with size of tumor (5cm), without portal venous thrombosis. The results have shown that the rate of ephafetoprotein (AFP)- L3 after the treatment by TOCE related closely with relapsing time of cancer and survival duration and image of CT scanner after the treatment.

Esophageal venous ligation in patients with cirrhosis

The esophageal venous ligation in patients with cirrhosis accompanying the esophageal varices. The efficacy of esophageal venous ligation related closely (p=0,05) with the liver failure level. There was no relation between efficacy of technique with level of esophageal venous varices.

Clinical and histological features of colon polyps

A study on 97 patients with polyps diagnosed by endoscopy in central army hospital during 2000-2002 has shown that male/female (69/28), average ages (50), patients with one polyp, 2 polyps, 3 polyps, 4 polyps, 7 polyps and 8 polyps were 78, 15, 1, 1,1 and (1) respectively. The symptoms comprised abdominal pain (56%), dyspepsia (50%) blood and mucosa in feces (13%). Polyps concentrated in peripheral colon (43.80%). The rate of patients diagnosed early accounted for 4.2%